| Nov 12 |
Cytokinetics to Participate in the 2024 Jefferies London Healthcare Conference
|
| Nov 11 |
Cytokinetics initiates phase 1 clinical study of muscle troponin activator CK-089
|
| Nov 11 |
Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-4015089
|
| Nov 8 |
Cytokinetics started at outperform by RBC, valuation cited
|
| Nov 8 |
Cytokinetics Third Quarter 2024 Earnings: Misses Expectations
|
| Nov 7 |
Cytokinetics Inc (CYTK) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial ...
|
| Nov 7 |
Cytokinetics, Incorporated (CYTK) Q3 2024 Earnings Call Transcript
|
| Nov 6 |
Cytokinetics (CYTK) Reports Q3 Loss, Lags Revenue Estimates
|
| Nov 6 |
Cytokinetics: Q3 Earnings Snapshot
|
| Nov 6 |
Cytokinetics GAAP EPS of -$1.36, revenue of $0.5M
|
